• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    AcelRx Pharmaceuticals, Inc. (ACRX)

    -NasdaqGM
    3.50 Up 0.05(1.45%) May 29, 4:00PM EDT
    |After Hours : 3.50 0.00 (0.00%) May 29, 4:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 181   226   4,825   71  
    Cost of Revenue -   -   -   -  
    Gross Profit 181   226   4,825   71  
    Operating Expenses
    Research Development6,306  7,281  5,244  7,284  
    Selling General and Administrative4,521  4,724  4,650  5,047  
    Non Recurring754   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (11,400) (11,779) (5,069) (12,260)
    Income from Continuing Operations
    Total Other Income/Expenses Net2,180  (1,218)6,556  2,215  
    Earnings Before Interest And Taxes(9,220)(12,997)1,487  (10,045)
    Interest Expense806  821  816  530  
    Income Before Tax(10,026)(13,818)671  (10,575)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(10,026)(13,818)671  (10,575)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,026) (13,818) 671   (10,575)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,026) (13,818) 671   (10,575)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.